ONCASPAR

Product Overview

About ONCASPAR

ONCASPAR is a medication used in the treatment of acute lymphoblastic leukemia (ALL) in pediatric and adult patients. It is a pegylated form of L-asparaginase, an enzyme that works by depleting the amino acid asparagine, which is essential for the growth and survival of cancer cells.

Key Benefits & Uses

• Treatment of acute lymphoblastic leukemia (ALL) in pediatric and adult patients
• Used in combination with other chemotherapy medications to achieve remission and prevent relapse
• May be used as part of a maintenance therapy regimen to prevent cancer recurrence

Active Ingredient & Action

ONCASPAR contains the active ingredient pegaspargase, a pegylated form of L-asparaginase. Pegaspargase works by depleting the amino acid asparagine, which is essential for the growth and survival of cancer cells. As a result, cancer cells are unable to produce the proteins necessary for their growth and proliferation, leading to cell death and tumor shrinkage.

Important Notes

ONCASPAR should only be used under the guidance of a qualified healthcare professional. Patients with a history of pancreatitis or other pancreatic disorders should be closely monitored for signs of pancreatitis. Common side effects of ONCASPAR include pancreatitis, allergic reactions, and thrombosis. Patients should report any unusual symptoms or side effects to their healthcare provider promptly.